References
- MarquisJSchneiderMPPayotVSwallowing difficulties with oral drugs among polypharmacy patients attending community pharmaciesInt J Clin Pharm20133561130113623963541
- SchieleJTQuinzlerRKlimmHDPruszydloMGHaefeliWEDifficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage formsEur J Clin Pharmacol201369493794823052416
- SpeyerRCordierRKertscherBHeijnenBJPsychometric properties of questionnaires on functional health status in oropharyngeal dysphagia: a systematic literature reviewBio Med Res Int20142014458678
- DwivediRCRoseSStRoeJWValidation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patientsOral Oncol2010464e10e1420219415
- AntoniosNCarnaby-MannGCraryMAnalysis of a physician tool for evaluating dysphagia on an inpatient stroke unit: the modified Mann Assessment of Swallowing AbilityJ Stroke Cerebrovasc Dis2010191495720123227
- KellyJD’CruzGWrightDPatients with dysphagia: experiences of taking medicationJ Adv Nurs2010661829119968724
- RoederBEMurrayJADierkhisingRAPatient localization of esophageal dysphagiaDig Dis Sci200449469770115185881
- SmithDFOttDJGelfandDWChenMYLower esophageal mucosal ring: correlation of referred symptoms with radiographic findings using a marshmallow bolusAJR Am J Roentgenol19981715136113659798879
- RanqueBMouthonLGeoepidemiology of systemic sclerosisAutoimmun Rev201095A311A31819906362
- Coral-AlvaradoPPardoALCastano-RodriguezNRojas-VillarragaAAnayaJMSystemic sclerosis: a world wide global analysisClin Rheumatol200928775776519277816
- VischioJSaeedFKarimeddiniMProgression of esophageal dysmotility in systemic sclerosisJ Rheumatol201239598699122382346
- EbertECEsophageal disease in sclerodermaJ Clin Gastroenterol200640976977517016130
- PierceJTannerKMerrillRMillerKKendallKRoyNSwallowing disorders in Sjögren’s syndrome: prevalence, risk factors, and effects on quality of lifeDysphagia2016311495926482060
- PopeJHardingSKhimdasSBonnerABaronMAgreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research GroupJ Rheumatol201239352453122247347
- LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339b270019622552
- MoherDLiberatiATetzlaffJAltmanDGPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253519622551
- AltmanDGPractical Statistics for Medical ResearchLondonChapman and Hall1991
- van den HoogenFKhannaDFransenJ2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnn Rheum Dis201372111747175524092682
- SchunemannHJOxmanADBrozekJGrading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ200833676531106111018483053
- WrightDMedication administration in nursing homesNurs Stand200216423338
- FoxRISaitoICriteria for diagnosis of Sjogren’s syndromeRheum Dis Clin North Am19942023914078016418
- DanielsTECriswellLAShiboskiCAn early view of the international Sjogren’s syndrome registryArthritis Rheum200961571171419405009
- MatsuoKPalmerJBAnatomy and physiology of feeding and swallowing: normal and abnormalPhys Med Rehabil Clin N Am2008194691707vii18940636
- SaconatoMChiariBMLedermanHMGoncalvesMIEffectiveness of Chin-tuck Maneuver to Facilitate Swallowing in Neurologic DysphagiaInt Arch Otorhinolaryngol2016201131726722339
- MesserliMBlozikEVriendsNHersbergerKEImpact of a community pharmacist-led medication review on medicines use in patients on polypharmacy – a prospective randomised controlled trialBMC Health Serv Res201616114527108410
- ArnetIMetaxasCWalterPNMoriskyDEHersbergerKEThe 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patientsJournal of Evaluation in Clinical Practice201521227127725558796
- Swiss agency for therapeutic products (Swissmedic)Product information2015 Available from: http://swissmedicinfo.ch/Accept.aspx?Lang=ENAccessed December 12, 2015
- VitaliCBorghiENapoletanoAOropharyngolaryngeal disorders in scleroderma: development and validation of the SLS scaleDysphagia201025212713819707819
- EdwardsDAWDiscriminatory value of symptoms in the differential diagnosis of dysphagiaClin Gastroenterol1976514957
- SpiegelBMRHaysRDBolusRDevelopment of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scalesAm J Gastroenterol2014109111804181425199473
- BaronMHudsonMSteeleRLoEValidation of the UCLA scleroderma clinica trial gastrointestinal tract Instrument version 2.0 for systemic sclerosisJ Rheumatol20113891925193021724704
- LauETLSteadmanKJMakMCicheroJAYNissenLMPrevalence of swallowing difficulties and medication modification in customers of community pharmacistsJ Pharm Pract Res20154511823
- SchieleJTSchneiderHQuinzlerRReichGHaefeliWETwo techniques to make swallowing pills easierAnn Fam Med201412655055225384817
- GadallahMABoulosDNGebrelADewedarSMoriskyDEAssessment of rheumatoid arthritis patients’ adherence to treatmentAm J Med Sci2015349215115625474222
- BozekAJarzabJAdherence to asthma therapy in elderly patientsJ Asthma201047216216520170323
- GualtierottiRIngegnoliFScaloneLFeasibility, acceptability and construct validity of EQ-5D in systemic sclerosisSwiss Med Wkly2017146w1439428102877